Studies on the use of "prophylactic" intrathecal amethopterin in childhood leukemia.
D002493:Central Nervous System Diseases / Q000209:etiology / Q000517:prevention & control*; D002555:Cerebrospinal Fluid; D002556:Cerebrospinal Fluid Proteins; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D007938:Leukemia / Q000150:complications / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D007958:Leukocyte Count; D007962:Leukocytes; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000008:administration & dosage*; D011241:Prednisone / Q000627:therapeutic use; D013129:Spinal Puncture; D014750:Vincristine / Q000627:therapeutic use
D002556:Cerebrospinal Fluid Proteins; D014750:Vincristine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate